PPRC1 is an activator of mitochondrial biogenesis, a process regulated by mTOR (Morita et al., 2013; Ramanathan and Schreiber, 2009; Schieke et al., 2006), highlighting the use of mTOR inhibitors in cancers with aberrant mitochondrial activity. Here, PPRC1 is linked to cancer.